A pan-cancer analysis of tumor-infiltrating B cell repertoires

Tumor-infiltrating B cells can play an important role in anti-tumor responses but their presence is not well understood. In this study, we extracted the B cell receptor repertoires from 9522 tumor and adjacent non-tumor samples across 28 tumor types in the Cancer Genome Atlas project and performed d...

ver descrição completa

Detalhes bibliográficos
Autores: Yu, Katharine, Ravoor, Akshay, Malats, Núria, Pineda Sanjuan, Silvia, Sirota, Marina
Tipo de documento: artigo
Data de publicação:2022
País:España
Recursos:Universidad Complutense de Madrid (UCM)
Repositório:Docta Complutense
Idioma:inglês
OAI Identifier:oai:docta.ucm.es:20.500.14352/102399
Acesso em linha:https://hdl.handle.net/20.500.14352/102399
Access Level:Acceso aberto
Palavra-chave:616-006.04
519.22-76
519.8
B cell repertoire
Immune repertoire
Tumor microenvironment
Tumor infiltration
TCGA
Oncología
Investigación operativa (Estadística)
3207.13 Oncología
2404.01 Bioestadística
1207 Investigación Operativa
Descrição
Resumo:Tumor-infiltrating B cells can play an important role in anti-tumor responses but their presence is not well understood. In this study, we extracted the B cell receptor repertoires from 9522 tumor and adjacent non-tumor samples across 28 tumor types in the Cancer Genome Atlas project and performed diversity and network analysis. We identified differences in diversity and network statistics across tumor types and subtypes and observed a trend towards increased clonality in primary tumors compared to adjacent non-tumor tissues. We also found significant associations between the repertoire features and mutation load, tumor stage, and age. Our V-gene usage analysis identified similar V-gene usage patterns in colorectal and endometrial cancers. Lastly, we evaluated the prognostic value of the repertoire features and identified significant associations with survival in seven tumor types. This study warrants further research into better understanding the role of tumor-infiltrating B cells across a wide range of tumor types.